Mohankumar K. Murugesan Profile
Mohankumar K. Murugesan

@MohankumarKMur1

Followers
56
Following
6
Media
0
Statuses
17

Joined May 2018
Don't wanna be here? Send us removal request.
@MohankumarKMur1
Mohankumar K. Murugesan
9 months
Excited to share our publication highlighting the use of nickase-deficient base editors to overcome interstitial deletions in homologous regions .Thanks to everyone involved!. @CSCR_CMC_inStem @DBT_inStem @DBTIndia.#baseediting #CRISPR.
cell.com
Mohankumar and colleagues show that DNA nicks are the main cause for the formation of indels and large deletions while using base editors in homologous regions. They describe the use of a nickase-d...
1
1
5
@MohankumarKMur1
Mohankumar K. Murugesan
1 year
Delighted to share our lab's latest paper published in Molecular Therapy Nucleic Acids on correction of various β-thalassemia mutations in coding and non-coding regions using base editors”.DOI:
0
0
0
@MohankumarKMur1
Mohankumar K. Murugesan
1 year
Excited to share our latest research work published on Molecular therapy. We performed a structural/function analysis of the BCL11A-XL specific ZnF domains unraveling exciting functions of the C-terminal ZnF domains of the longer isoform.
2
5
11
@MohankumarKMur1
Mohankumar K. Murugesan
2 years
Pleased to share our work on the use of nickase-deficient base editors to avoid large deletions while editing the highly homologous regions such as the therapeutically relevant HBG promoters.. #baseediting #sicklecellanemia .#CRISPR #genomeediting.
biorxiv.org
Base editing in gamma-globin promoter is a promising approach for reactivation of fetal-hemoglobin. Recent studies have shown that base editing could result in genotoxic events at the gamma globin...
0
2
7
@MohankumarKMur1
Mohankumar K. Murugesan
3 years
Thanks to @eLifeCommunity for this award. It would not be possible without the support from @CSCR_CMC_inStem @DBT_inStem @DBTIndia.
@eLifeCommunity
eLife Community
3 years
Kumarasamypet Mohankumar (@MohankumarKMur1) aims to develop genome-editing strategies to treat genetic blood disorders. He says the award will “help us extend our published preclinical work to in vivo models and, in turn, evaluate its potential clinical applications”.
Tweet media one
4
3
23
@MohankumarKMur1
Mohankumar K. Murugesan
3 years
RT @eLifeCommunity: Kumarasamypet Mohankumar (@MohankumarKMur1) aims to develop genome-editing strategies to treat genetic blood disorders.….
0
1
0
@MohankumarKMur1
Mohankumar K. Murugesan
3 years
RT @eLifeCommunity: We’re delighted to introduce the 10 winners and two runners-up of this year’s Ben Barres Spotlight Awards! 🎉. And this….
0
11
0
@MohankumarKMur1
Mohankumar K. Murugesan
3 years
RT @biorxivpreprint: Precise modelling and correction of a spectrum of β-thalassemic mutations in human erythroid cells by base editors ht….
0
2
0
@MohankumarKMur1
Mohankumar K. Murugesan
3 years
RT @DBTIndia: Scientists have shed light on so far unknown regulatory elements within the HBG promoter and identified additional targets fo….
0
12
0
@MohankumarKMur1
Mohankumar K. Murugesan
3 years
RT @DBT_inStem: In a recent study published in @ACSPublications , @srujannano in collaboration with @pkvemula developed a self-skin permeab….
0
4
0